` Comparison: RGEN, 207940 - Alpha Spread

RGEN
vs
207940

Over the past 12 months, RGEN has underperformed Samsung Biologics Co Ltd, delivering a return of -22% compared to the Samsung Biologics Co Ltd's +11% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RGEN
207940
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

RGEN Intrinsic Value
70.23 USD
Overvaluation 45%
Intrinsic Value
Price
Intrinsic Value
670 029.33 KRW
Overvaluation 35%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Repligen Corp
NASDAQ:RGEN
127.15 USD
Samsung Biologics Co Ltd
KRX:207940
1 031 500 KRW
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RGEN, 207940

RGEN
207940
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Repligen Corp
Revenue
Samsung Biologics Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
RGEN, 207940

RGEN
207940
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Repligen Corp
NASDAQ:RGEN
Samsung Biologics Co Ltd
KRX:207940
What is Free Cash Flow?

Gross Margin

RGEN
50.7%
Samsung Biologics Co Ltd
53.2%

Operating Margin

RGEN
-3.5%
Samsung Biologics Co Ltd
32.4%

Net Margin

RGEN
-2.1%
Samsung Biologics Co Ltd
26.1%

FCF Margin

RGEN
17.8%
Samsung Biologics Co Ltd
2.8%

ROE

RGEN
-0.7%
Samsung Biologics Co Ltd
12%

ROA

RGEN
-0.5%
Samsung Biologics Co Ltd
7.5%

ROIC

RGEN
-1.2%
Samsung Biologics Co Ltd
8.2%

ROCE

RGEN
-0.9%
Samsung Biologics Co Ltd
12.3%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
RGEN, 207940

Loading
RGEN
207940
Add Stock
www.alphaspread.com

Performance Gap
RGEN, 207940

Loading
RGEN
207940
Difference
www.alphaspread.com

Performance By Year
RGEN, 207940

Loading
RGEN
207940
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RGEN to other stocks
Unlock Full Access to Alpha Spread
Create Free Account